Results 101 to 110 of about 417,097 (363)

Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union

Infectious Diseases and Therapy
Introduction The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare systems globally. The lack of quality guidelines on the management of COVID-19 in rheumatologic disease, renal disease, hematological malignancy,
Jaya Paranilam, Francesco Arcioni, Antonio Franco, Kira Zhi Hua Lai, Joseph Brown, Samantha Kimball-Carroll   +5 more
doaj   +1 more source

Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus

CPT: Pharmacometrics & Systems Pharmacology, 2023
Maribavir was approved by the US Food and Drug Administration for the treatment of patients aged ≥12 years and weighing ≥35 kg with posttransplant cytomegalovirus infection/disease refractory (with/without resistance) to valganciclovir, ganciclovir ...
Kefeng Sun, Siobhan Hayes, Colm Farrell, Ivy H. Song   +3 more
doaj   +1 more source

Synthetically Trained Icon Proposals for Parsing and Summarizing Infographics [PDF]

, 2018
Widely used in news, business, and educational media, infographics are handcrafted to effectively communicate messages about complex and often abstract topics including `ways to conserve the environment' and `understanding the financial crisis'. Composed of stylistically and semantically diverse visual and textual elements, infographics pose new ...
arxiv   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Molecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant   +14 more
wiley   +1 more source

Ice Bear: The Cultural History of an Arctic Icon by Michael Engelhard [PDF]

, 2017
Review of Michael Engelhard\u27s Ice Bear: The Cultural History of an Arctic ...
Pigeon, Geneviève
core   +2 more sources

Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations

Health and Quality of Life Outcomes, 2019
Background Acute infectious conjunctivitis is a common condition most frequently caused by viruses or bacteria. Clinical outcome assessments have been used to assess signs and symptoms of bacterial and viral conjunctivitis, but have not been evaluated ...
Sujata P. Sarda, Marie De La Cruz, Emuella M. Flood, Magdalena Vanya, David G. Hwang, Christopher N. Ta, Abhijit Narvekar   +6 more
doaj   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

ICON 2019: International Scientific Tendinopathy Symposium Consensus: Clinical Terminology [PDF]

, 2019
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.Background Persistent tendon pain that impairs function has inconsistent medical terms that can influence choice of treatment.1 When a person is ...
Akker-Scheek, I.V.D. (Inge Van Den), Alfredson, H. (Hakan), Bahr, R. (Roald), Cook, J.L. (Jill L.), Coombes, B. (Brooke), Fu, S.N. (Siu Ngor), Gravare Silbernagel, K. (Karin), Grimaldi, A. (Alison), Lewis, J.S. (Jeremy S), Maffulli, N. (Nicola), Magnusson, S.P. (S. P.), Malliaras, P. (Peter), Mc Auliffe, S. (Sean), Oei, E.H.G. (Edwin), Purdam, C.R. (Craig Robert), Rees, J.D. (Jonathan D), Rio, E.K. (Ebonie Kendra), Scott, A. (Alex), Speed, C. (Cathy), Squier, K. (Kipling), Vicenzino, B.T. (Bill T), Vos, R.J. (Robert-Jan) de, Weir, A. (Adam), Wolf, J.M. (Jennifer Moriatis), Zwerver, J. (Johannes)   +24 more
core   +3 more sources

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

Molecular Oncology, EarlyView.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina, Viviana Bazan, Nadia Barraco, Simona Taverna, Mauro Manno, Samuele Raccosta, Anna Paola Carreca, Marco Bono, Tancredi Didier Bazan Russo, Francesco Pepe, Pasquale Pisapia, Lorena Incorvaia, Giuseppe Badalamenti, Giancarlo Troncone, Umberto Malapelle, Daniele Santini, Antonio Russo, Antonio Galvano   +17 more
wiley   +1 more source